ENTITY
Mezzion Pharma

Mezzion Pharma (140410 KS)

21
Analysis
Health Care • South Korea
Mezzion Pharma Co Ltd develops pharmaceutical products and out-licenses them to foreign countries including Canada, Mexico, Russia, and the United States. The Company's main products are for benign prostatic hyperplasia and erectile dysfunction.
more
•01 Jun 2017 14:39

Summary of KOSPI200 & KOSDAQ150 Upcoming Reshuffle

As I said in my earlier comment, Samsung Biologics Co., Ltd (207940 KS) seems to be benefiting a lot from its inclusion in KOSPI200 index. Perhaps...

Logo
2.4k Views
Share
•07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.6k Views
Share
•25 Mar 2026 07:05

KRX Short Interest Weekly (Mar 20th): Samsung F&M Insurance, SamsungElecMech, DWEC, Samsung SDI

We analyzed KRX short interest report for the past week and highlighted short interest changes in Samsung F&M Insurance, SamsungElecMech, DWEC,...

Logo
233 Views
Share
•23 Mar 2026 07:05

KRX Foreign Holding Weekly (Mar 20th): Samsung Electronics, Hyundai Motor, SK Hynix, KIA, ISUPETASYS

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, Hyundai Motor, SK Hynix,...

Logo
317 Views
Share
•10 Sep 2025 07:10

KRX Short Interest Weekly (Sep 5th): Kakaopay, L&F, NAVER, SK Hynix, Alteogen

We analyzed KRX short interest report for the past week and highlighted short interest changes in kakaopay, L&F, NAVER, SK Hynix, Alteogen.

Logo
377 Views
Share
x